CDR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.11022302462516E-16 |
Normal-vs-Stage2 |
1.296240E-03 |
Normal-vs-Stage3 |
1.402480E-04 |
Normal-vs-Stage4 |
4.535700E-02 |
Stage1-vs-Stage2 |
9.701400E-01 |
Stage1-vs-Stage3 |
6.089000E-01 |
Stage1-vs-Stage4 |
8.488000E-01 |
Stage2-vs-Stage3 |
7.110600E-01 |
Stage2-vs-Stage4 |
8.951400E-01 |
Stage3-vs-Stage4 |
6.797200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.11022302462516E-16 |
Normal-vs-AfricanAmerican |
2.74899999996858E-06 |
Normal-vs-Asian |
1.753040E-01 |
Caucasian-vs-AfricanAmerican |
1.270190E-02 |
Caucasian-vs-Asian |
6.843200E-01 |
AfricanAmerican-vs-Asian |
6.445000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
9.59110002529684E-09 |
Male-vs-Female |
5.928100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.82200000000177E-05 |
Normal-vs-Extreme_Weight |
1.66078262253677E-12 |
Normal-vs-Obese |
2.14949946730769E-10 |
Normal-vs-Extreme_Obese |
2.366300E-02 |
Normal_Weight-vs-Extreme_Weight |
2.330300E-02 |
Normal_Weight-vs-Obese |
4.054300E-02 |
Normal_Weight-vs-Extreme_Obese |
3.626400E-01 |
Extreme_Weight-vs-Obese |
9.585000E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.126600E-01 |
Obese-vs-Extreme_Obese |
7.493800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.974700E-04 |
Normal-vs-Age(41-60Yrs) |
<1E-12 |
Normal-vs-Age(61-80Yrs) |
8.88178419700125E-16 |
Normal-vs-Age(81-100Yrs) |
7.034500E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.142600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.830380E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.008200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.232500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.880400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.331400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
<1E-12 |
Normal-VS-Type2 PRCC |
1.42599999997106E-06 |
Normal-VS-KIRP CIMP |
7.363500E-03 |
Normal-VS-Unclassified PRCC |
7.41649999969063E-07 |
Type1 PRCC-VS-Type2 PRCC |
1.433630E-02 |
Type1 PRCC-VS-KIRP CIMP |
1.396200E-04 |
Type1 PRCC-VS-Unclassified PRCC |
9.491200E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.034170E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.147200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
3.798800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.9211000000261E-06 |
Normal-vs-N1 |
1.017160E-03 |
Normal-vs-N2 |
1.183020E-01 |
N0-vs-N1 |
5.112600E-01 |
N0-vs-N2 |
9.251200E-01 |
N1-vs-N2 |
8.375600E-01 |
|
|